Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?
Theocharis KoufakisMichael N DoumasAlexandra BargiotaKalliopi KotsaGiuseppe MaltesePublished in: Expert review of clinical pharmacology (2023)